3-[4-[3-[3-[2-[2-[2-[2-[4-[2-[2-[2-[2-[[5-[3-[2,6-dimethyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenoxy]propyl]isoxazol-3-yl]methoxy]ethoxy]ethoxy]ethoxy]ethoxymethyl]benzyl]oxyethoxy]ethoxy]ethoxy]ethoxymethyl]isoxazol-5-yl]propoxy]-3,5-dimethyl-phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole
Compound with spectra: 1 NMR
![3-[4-[3-[3-[2-[2-[2-[2-[4-[2-[2-[2-[2-[[5-[3-[2,6-dimethyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenoxy]propyl]isoxazol-3-yl]methoxy]ethoxy]ethoxy]ethoxy]ethoxymethyl]benzyl]oxyethoxy]ethoxy]ethoxy]ethoxymethyl]isoxazol-5-yl]propoxy]-3,5-dimethyl-phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole](/api/compound/4AtRsY4WvXY.png?ph=true&h=300&w=458 "3-[4-[3-[3-[2-[2-[2-[2-[4-[2-[2-[2-[2-[[5-[3-[2,6-dimethyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenoxy]propyl]isoxazol-3-yl]methoxy]ethoxy]ethoxy]ethoxy]ethoxymethyl]benzyl]oxyethoxy]ethoxy]ethoxy]ethoxymethyl]isoxazol-5-yl]propoxy]-3,5-dimethyl-phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole")
| SpectraBase Compound ID | 4AtRsY4WvXY |
|---|---|
| InChI | InChI=1S/C60H74F6N6O16/c1-41-31-47(55-67-57(87-71-55)59(61,62)63)32-42(2)53(41)83-13-5-7-51-35-49(69-85-51)39-81-29-25-77-21-17-73-15-19-75-23-27-79-37-45-9-11-46(12-10-45)38-80-28-24-76-20-16-74-18-22-78-26-30-82-40-50-36-52(86-70-50)8-6-14-84-54-43(3)33-48(34-44(54)4)56-68-58(88-72-56)60(64,65)66/h9-12,31-36H,5-8,13-30,37-40H2,1-4H3 |
| InChIKey | FJCZXPJRTYBIGA-UHFFFAOYSA-N |
| Mol Weight | 1249.3 g/mol |
| Molecular Formula | C60H74F6N6O16 |
| Exact Mass | 1248.506549 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | ACETONE-D6 |
3-[4-[3-[3-[2-[2-[2-[2-[2-[2-[4-[2-[2-[2-[2-[2-[2-[[5-[3-[2,6-dimethyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenoxy]propyl]isoxazol-3-yl]methoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxymethyl]benzyl]oxyethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxymethyl]isoxazol-5-yl]propoxy]-3,5-dimethyl-phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole
3-[4-[3-[3-[2-[2-[2-[4-[2-[2-[2-[[5-[3-[2,6-dimethyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenoxy]propyl]isoxazol-3-yl]methoxy]ethoxy]ethoxy]ethoxymethyl]benzyl]oxyethoxy]ethoxy]ethoxymethyl]isoxazol-5-yl]propoxy]-3,5-dimethyl-phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole
1,4-BIS-([5-[3-[2,6-DIMETHYL-4-(5-TRIFLUOROMETHYL-1,2,4-OXADIAZOLYL)-PHENOXY]-PROPYL]-ISOXAZOLYL-3-METHYLOXY]-ETHOXYETHOXYMETHYL)-BENZENE
2,2-DIFLUORO-2-(3-PHENYL-[1,2,4]-OXADIAZOL-5-YL)-1-[4-(TRIFLUOROMETHYL)-PHENYL]-ETHANOL
1,2,4-Oxadiazole, 3-(1,3-benzodioxol-5-yl)-5-[2-(4-methoxyphenyl)ethyl]-
1,2,4-Oxadiazole, 3-(1,3-benzodioxol-5-yl)-5-[(4-methoxyphenyl)methyl]-
1,2,4-oxadiazole-5-carboxamide, N-[2-[[2-(4-chloro-3-methylphenoxy)acetyl]amino]ethyl]-3-(3-methylphenyl)-
1,2,4-oxadiazole, 3-(3,4-dimethoxyphenyl)-5-[2-(3,5-dimethyl-1H-pyrazol-4-yl)ethyl]-
1,2,4-oxadiazole, 3-(3,4-dimethoxyphenyl)-5-[(2-methylphenoxy)methyl]-
Ethyl 2-{3-[2,2-difluoro-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]oxiran-2-yl}acetate
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Antiviral Activity of Dimeric Capsid-Binding Inhibitors of Human Rhinovirus (HRV) | Australian Journal of Chemistry | 2004 |